参考文献/References:
[1] Robinson P. Hepatocellular carcinoma:Development and early detection.Cancer imaging, 2008, 8 (special issue A):5128-131.
[2] Mariappan YK, Glaser KJ, Ehman RL. Magnetic resonance elastography:A review[J]. Clin Anat, 2010, 23 (5):497-511.
[3] Ophir J, Cespedes I, Ponnekanti H, et al. Elastography:A quantitative method for imaging the elasticity of biological tissues[J]. Ultrason imaging, 1991, 13(2):111-134.
[4] 张丽娜,刘爱连.腹部磁共振弹性成像研究进展[J].国际医学放射学杂志,2011,34(4):342-344.
[5] Glaser KJ, Manduca A, Ehman RL. Review of MR elastography applications and recent developments[J]. J Magn Reson Imaging,2012,36(4):757-774.
[6] Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver:Technique, analysis, and clinical applications[J]. J Magn Reson Imaging, 2013, 37 (3):544-555.
[7] Talwalkar JA, Yin M, Fidler JL, et al. Magnetic resonance imaging of hepatic fibrosis:Emerging clinical applications[J]. Hepatology,2008,47(1):332-342.
[8] Asbach P, Klatt D, Schlosser B, et al. Viscoelasticity-based staging of hepatic fibrosis with multifrequency mr elastography 1[J]. Radiology, 2010, 257 (1):80-86.
[9] Motosugi U, Ichikawa T, Sano K, et al. Magnetic resonance elastography of the liver:Preliminary results and estimation of inter-racer reliability[J]. Jpn J Radiol, 2010, 28 (8):623-627.
[10] Rustogi R, Horowitz J, Harmath C, et al. Accuracy of mr elastography and anatomic mr imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis[J]. J Magn Reson Imaging, 2012,35(6):1356-1364.
[11] Kim BH, Lee JM, Lee YJ, et al. MR elastography for noninvasive assessment of hepatic fibrosis:Experience from a tertiary center in Asia[J]. J Magn Reson Imaging, 2011, 34(5):1110-1116.
[12] Ehman E, Rossman P, Kruse S, et al. Vibration safety limits for magnetic resonance elastography[J]. Phys Med Biol, 2008, 53 (4):925-935.
[13] Bataller R, Brenner DA. Liver fibrosis[J]. J Clin Invest, 2005, 115(2):209-218.
[14] Friedman SL, Bansal MB. Reversal of hepatic fibrosis-fact or fantasy?[J]. Hepatology, 2006, 43 (Suppl 1):S82-88.
[15]Fowell AJ，Iredale JP．Emerging therapies for liver fibrosis[J]．Dig Dis, 2006, 24(1-2): 174-183．
[16] Godfrey EM, Mannelli L, Griffin N, et al. Magnetic resonance elastography in the diagnosis of hepatic fibrosis.Semin Ultrasound CT MR, 2013, 34 (1):81-88.
[17] Bonekamp S, Kamel I, Solga S, et al. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately[J]. J Hepatol, 2009, 50(1):17-35.
[18] Huwart L, Sempoux C, Vicaut E, et al. Magnetic resonance elastography for the noninvasive staging of liver fibrosis[J]. Gastroenterology, 2008, 135 (1):32-40.
[19] Venkatesh SK, Wang G, Lira SG, et al. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B[J]. Eur Radiol, 2014, 24(1):70-78.
[20] Hines CD, Bley TA, Lindstrom M J, et al. Repeatability of magnetic resonance elastography for quantification of hepatic stiffness[J]. J Magn Reson Imaging, 2010, 31(3):725-731.
[21] Shire NJ, Yin M, Chert J, et al. Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C[J]. J Magn Reson Imaging, 2011, 34(4):947-955.
[22] Venkatesh SK,Wang G,Teo LL,et al.Magnetic resonance elastography of liver in healthy asians:Normal liver stiffness quantification and reproducibility assessment[J].J Magn Reson Imaging, 2014,39(1):1-8.
[23] Xanthakos SA, Podberesky DJ, Serai SD, et al. Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease[J]. J Pediatr, 2014, 164(1):186-188.
[24] Rouviere O, Yin M, Dresner MR, et al. MR elastography of the liver:preliminary results[J]. Radiology, 2006, 240(2):440-448.
[25] Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography[J]. Clin Gastroenterol Hepatol, 2007, 5(10):1207-1213.
[26] Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver:Clinical applications[J]. J Comput Assist Tomogr, 2013, 37(6):887-896.
[27] Godfrey EM, Patterson AJ, Priest AN, et al. A comparison of MR elastography and 31p MR spectroscopy with histological staging of liver fibrosis[J]. Eur Radiol, 2012, 22(12):2790-2797.
[28] 石喻,郭启勇,张兰,等.3.0TMR弹性成像评价健康者及慢性肝病患者肝弹性值的初步研究[J].中华放射学杂志,2013,47(11):1005-1008.
[29] Huwart L, Sempoux C, Salameh N, et al. Liver fibrosis:Noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index[J]. Radiology, 2007, 245(2):458-466.
[30] Nedredal GI, Yin M, McKenzie T, et al. Portal hypertension correlates with splenic stiffness as measured with MR elastography[J]. J Magn Reson Imaging, 2011, 34(1):79-87.
[31] Yin M, Kolipaka A, Woodrum DA, et al. Hepatic and splenic stiffness augmentation assessed with MR elastography in an in vivo porcine portal hypertension model[J]. J Magn Reson Imaging, 2013, 38(4):809-815.
[32] Talwalkar JA, Yin M, Venkatesh S, et al. Feasibility and significance of in vivo mean spleen stiffness measurement by magnetic resonance elastography for assessing portal hypertension[J]. AJR Am J Roentgenol, 2009, 193(1):122-127.
[33] Morisaka H, Motosugi U, Ichikawa S, et al. Association of splenic MR elastographic findings with gastroesophageal varices in patients with chronic liver disease[J/OL]. J Magn Reson Imaging, 2013[2014-01-10]. http://onlinelibrary.wiley.com/doi/10.1002/jmri.24505/pdf.[published online ahead of print Nov 14, 2013].
[34] Mannelli L, Godfrey E, Joubert I, et al. MR elastography:Spleen stiffness measurements in healthy volunteers-preliminary experience[J]. AJR Am J Roentgenol, 2010, 195(2):387-392.
[35] Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis:Adenomatous hyperplasia and early hepatocellular carcinoma[J]. Hum Pathol, 1991, 22(2):172-178.
[36] Motosugi U, Ichikawa T, Koshiishi T, et al. Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma:A preliminary case-control study[J]. Eur Radiology, 2013, 23(1):156-162.
[37] Anaparthy R, Talwalkar J, Yin M, et al. Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis[J]. Aliment Pharmacol Ther, 2011, 34(1):83-91.
[38] Venkatesh SK, Yin M, Glockner JF, et al. MR elastography of liver tumors:Preliminary results[J]. AM J Roentgenol, 2008, 190(6):1534-1540.
[39] Garteiser P, Doblas S, Daire JL, et al. MR elastography of liver tumours:Value of viscoelastic properties for tumour characterisation[J]. Eur Radiol, 2012, 22(10):2169-2177.
[40] Doblas S, Garteiser P, Haddad N, et al. Magnetic resonance elastography measurements of viscosity:A novel biomarker for human hepatic tumor malignancy?[J]. Proc Intl Sac Mag Reson Med, 2011, 19:389.
[41] Chen J, Woodrum DA, Glaser KJ, et al. Assessment of in vivo laser ablation using MR elastography with an inertial driver[J]. Magn Reson Med, 2014, 72(1):59-67.
相似文献/References:
[1]姚晔,戈伟强,周云,等.BP神经网络模型预测肝肿瘤运动趋势可行性研究[J].国际放射医学核医学杂志,2016,40(1):22.[doi:10.3760/cma.j.issn.1673-4114.2016.01.005]
Yao Ye,Ge Weiqiang,Zhou Yun,et al.Feasibility study on liver tumor motion prediction based on back propagation neural network[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(4):22.[doi:10.3760/cma.j.issn.1673-4114.2016.01.005]
[2]方京龙,刘淑玲,张广明.肝硬化和肝癌MRI诊断研究进展[J].国际放射医学核医学杂志,2014,38(3):207.[doi:10.3760/cma.j.issn.1673-4114.2014.03.015]
Fang Jinglong,Liu Shuling,Zhang Guangming.Advances in MRI diagnosis of cirrhosis and hepatocellular[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(4):207.[doi:10.3760/cma.j.issn.1673-4114.2014.03.015]
[3]沈秀,刘晓秋,周则卫,等.昆明-无毛小鼠生物学特性的研究[J].国际放射医学核医学杂志,2013,37(2):74.[doi:10.3760/cma.j.issn.1673-4114.2013.02.003]
SHEN Xiu,LIU Xiao-qiu,ZHOU Ze-wei,et al.Biological characteristic of Kunming-hairless mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):74.[doi:10.3760/cma.j.issn.1673-4114.2013.02.003]
[4]刘晓秋,王芹,周则卫,等.9401对H22肝癌小鼠放射增敏效应的研究[J].国际放射医学核医学杂志,2013,37(1):13.[doi:10.3760/cma.j.issn.1673-4114.2013.01.004]
LIU Xiao-qiu,WANG Qin,ZHOU Ze-wei,et al.Radiosensitizing effects of 9401 on mice bearing H22 hepatoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):13.[doi:10.3760/cma.j.issn.1673-4114.2013.01.004]
[5]王月英,吴红英,李德冠,等.小鼠不同肿瘤模型对放化疗敏感性的研究[J].国际放射医学核医学杂志,2012,36(5):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
WANG Yue-ying,WU Hong-ying,LI De-guan,et al.The radiation sensitivities of different mice tumor model to radiotherapy and chemotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2012,36(4):289.[doi:10.3760/cnla.j.issn.1673-4114.2012.05.006]
[6]闫玉军,徐文清,刘晓秋,等.实验肿瘤局部照射动物模型的改进[J].国际放射医学核医学杂志,2013,37(6):337.[doi:10.3760/cma.j.issn.1673-4114.2013.06.003]
YAN Yu-jun,XU Wen-qing,LIU Xiao-qiu,et al.Improvement on the animal model of local irradiation for experimental tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(4):337.[doi:10.3760/cma.j.issn.1673-4114.2013.06.003]
[7]谢燃,李琳,邓智勇,等.18F-FDG耳关合11C-乙酸盐PET-CT在肝癌诊断中的应用[J].国际放射医学核医学杂志,2011,35(3):167.[doi:10.3760/cma.j.issn.1673-4114.2011.03.008]
XIE Ran,LI Lin,DENG Zhi-yong,et al.The applications of 18F-FDG combined with 11C-acetate PET-CT imaging in the diagnosis of hepatic cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2011,35(4):167.[doi:10.3760/cma.j.issn.1673-4114.2011.03.008]
[8]张颖,林军.125I粒子治疗对肝癌细胞凋亡及细胞周期的影响[J].国际放射医学核医学杂志,2009,33(4):193.[doi:10.3760/cma.j.issn.1673-4114.2009.04.001]
ZHANG Ying,LIN Jun.Effects of 125I seed brachytherapy on apoptosis and cell cycle distribution in hepatoma carcinoma cells[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(4):193.[doi:10.3760/cma.j.issn.1673-4114.2009.04.001]
[9]冯学民,尹乐,王俊起,等.呋塞米介入及增加核素活度对肝癌和肝硬化患者骨显像的改善[J].国际放射医学核医学杂志,2008,32(2):79.
FENG Xue-min,YIN Le,WANG Jun-qi,et al.The influence of bone scintigraphy in hepatic carcinoma and hepatocirrhosis with furosemide interventional test and increase radioactivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):79.
[10]冯彦林,谭家驹,梁生,等.抗人肝癌188Re-免疫磁性纳米微粒的生物学分布和肿瘤细胞抑制实验[J].国际放射医学核医学杂志,2007,31(6):321.
FENG Yan-lin,TAN Jia-jü,LIANG Sheng,et al.Experimental study of the biological properties of 188Re-Hepama-1 biologic superparamagnetic nanoparticles[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(4):321.